Loading...
Inclisiran for the Treatment of Cardiovascular Disease: A Short Review on the Emerging Data and Therapeutic Potential
Proprotein convertase subtilisin kexin 9 (PCSK-9)-targeting therapy has arisen as a new line for the treatment of hyperlipidemia. Inclisiran is a double-stranded small RNA molecule that works by blocking the transcription of PCSK-9, leading to a reduction of PCSK9 levels in the hepatocytes, resultin...
Na minha lista:
| Udgivet i: | Ther Clin Risk Manag |
|---|---|
| Main Authors: | , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Dove
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7604242/ https://ncbi.nlm.nih.gov/pubmed/33149595 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/TCRM.S230592 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|